Reporter Staff
| This email address is being protected from spambots. You need JavaScript enabled to view it.
May 28, 2024
We are looking for those with high blood pressure and a BMI over 30 to participate in a study
Participate in the PRECISION-BP research study investigating the best time to take blood pressure medication, morning or evening. This study participants will receive blood pressure medications for 28 days. Eligible participants must be obese (BMI: 30-45 kg/m2) men and women, have high blood pressure, and have no history of heart or kidney problems. The study involves wearing a blood pressure monitor for 24 hours, 24-hour inpatient visits at UAB Hospital, taking medications, and collecting blood and urine samples. Meals will be provided at no cost. Participants will be compensated $575 for completing the study visits. Please e-mail Haley at PRECISION-BPSTUDY@uabmc.edu or call us at 205-975-5825 if you are interested.
Published in
Clinical Trials
You may be eligible to participate in a research study looking at the effects of sacubitril/valsartan on how your body handles sugar. This medication is related to blood pressure and is safe to take with or without hypertension. Eligible participants must be healthy men and women, African American, and have no history of diabetes, heart disease or kidney problems. The study involves performing some exercise, taking sacubitril/valsartan, and collecting blood samples. Participants will be compensated $675 for completing all the visits. To participate, please contact Tiffany at 205-934-0534 or email us at nauticalstudy@uabmc.edu.
Published in
Clinical Trials
Eligible participants must be healthy adults (BMI less than 45 kg/m2) and have no history of diabetes, heart problems, or kidney problems. The study involves consuming prepared meals, performing exercise on a treadmill, undergoing a glucose test, and collecting blood, urine samples, and collection of genetic information. Participants will be compensated $300 for completing all the visits and meals will be provided at no cost. Please e-mail us at genesis@uabmc.edu or call us at (205) 975-3956 if you are interested.
Published in
Clinical Trials
According to the National Highway Traffic Safety Administration, auto thefts are a continued concern nationwide—and not just the contents inside the cars, but the cars themselves. These habits can help maintain a secure environment.
Published in
Campus Safety
May 17, 2024
Geurs named new School of Dentistry dean
Nicolaas Geurs, D.D.S., M.S., inaugural holder of UAB's Weatherford-Palcanis Endowed Professorship in Dentistry and the Dental Alumni-Joseph F. Volker Chair of Clinical Dentistry, has been selected as the next dean of the UAB School of Dentistry following a national search. He will begin his new role June 1.
Published in
Leadership
May 16, 2024
Updates on FLSA changes coming soon
The U.S. Department of Labor has announced a change to the criteria for determining employees’ status as nonexempt (paid bi-weekly) or exempt (paid monthly) under the Fair Labor Standards Act. This is not a UAB decision; it is a federal law all employers must follow.
Published in
Take Note
May 08, 2024
UAB Police holds promotion ceremony
The UAB Police and Public Safety Department held its first promotional ceremony on Jan. 3, 2024, recognizing officers and employees who have moved up the ranks for their dedication and committed service to the UAB Community.
Published in
Campus Safety
May 03, 2024
Healthy Women Needed for a Research Study
You may be eligible to participate in a research study: If you are a healthy female, between age of 18-50, still having a regular menstrual cycle & you are NOT on hormonal birth control (birth control pills or shots (i.e. Depo shot) or IUD, like Mirena). And, if you are willing to undergo an endometrial biopsy procedure and blood draw.
Participants will be compensated a total of $200. Only requires 2 visits.
For information, call us at 205-934-5498 or email: urogynecology@uabmc.edu
Participants will be compensated a total of $200. Only requires 2 visits.
For information, call us at 205-934-5498 or email: urogynecology@uabmc.edu
Published in
Clinical Trials
On May 6, join a virtual 30-minute session exploring the Career Goals feature in LinkedIn Learning, an online learning resource platform available at no cost to all benefit-eligible employees at UAB. Register today.
Published in
Learning & Development
A Phase 3, Randomized, Multicenter, Open-label Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared with Semaglutide Once Weekly in Adult Participants with Type 2 Diabetes and Inadequate Glycemic Control with Metformin with or without SGLT2 Inhibitor (TRANSCEND-T2D-2)
TRANSCEND-T2D-2 is a clinical research study for people with type 2 diabetes.
This study will test if an investigational medicine (the medicine being studied) can
help with blood glucose (sugar) and weight management compared with an existing
treatment for type 2 diabetes.
- Are aged 18 years or older
- Have type 2 diabetes
- Have been taking 1500mg or more of metformin each day for at least 3 months (with or without SGLT2i)
- Have a BMI of 25 or more
- Have HbA1c levels of 7.0% to 10.5%
To see if you qualify please contact at 205-996-4015, 205-934-5564 or via mail at tthoma@uab.edu or ccnrn@uab.edu
Published in
Clinical Trials
